tiprankstipranks
SAGE Therapeutics (SAGE)
NASDAQ:SAGE

SAGE Therapeutics (SAGE) Technical Analysis

857 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
2Neutral
16Bearish
Technical Analysis Consensus
Neutral
4Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
SAGE Therapeutics’s (SAGE) Moving Averages Convergence Divergence (MACD) indicator is -1.14, suggesting SAGE Therapeutics is a Sell.
SAGE Therapeutics’s (SAGE) 20-Day exponential moving average is 13.03, while SAGE Therapeutics’s (SAGE) share price is $11.7, making it a Sell.
SAGE Therapeutics’s (SAGE) 50-Day exponential moving average is 15.48, while SAGE Therapeutics’s (SAGE) share price is $11.7, making it a Sell.

SAGE Therapeutics (SAGE) Pivot Points

May 20, 2024, 04:57 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.96
11.22
11.61
11.87
12.26
12.52
12.91
Fibonacci
11.22
11.46
11.62
11.87
12.11
12.27
12.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SAGE Therapeutics (SAGE) Moving Averages

May 20, 2024, 04:57 AM
Period
Simple
Exponential
MA5
11.91Sell
11.93Sell
MA10
12.24Sell
12.26Sell
MA20
12.90Sell
13.03Sell
MA50
15.83Sell
15.48Sell
MA100
19.90Sell
18.43Sell
MA200
20.08Sell
23.19Sell
SAGE Therapeutics’s (SAGE) 10-Day exponential moving average is 12.26, while SAGE Therapeutics’s (SAGE) share price is $11.7, making it a Sell.
SAGE Therapeutics’s (SAGE) 100-Day exponential moving average is 18.43, while SAGE Therapeutics’s (SAGE) share price is $11.7, making it a Sell.
SAGE Therapeutics’s (SAGE) stock price is $11.7 and SAGE Therapeutics’s (SAGE) 50-day simple moving average is 15.83, creating a Sell signal.
SAGE Therapeutics’s (SAGE) stock price is $11.7 and SAGE Therapeutics’s (SAGE) 100-day simple moving average is 19.90, creating a Sell signal.
SAGE Therapeutics’s (SAGE) stock price is $11.7 and SAGE Therapeutics’s (SAGE) 200-day simple moving average is 20.08, creating a Sell signal.

SAGE Therapeutics (SAGE) Technical Indicators

May 20, 2024, 04:57 AM
Name
Value
Implied Action
RSI (14)
31.83
Neutral
STOCH (9,6)
10.94
Buy
STOCHRSI (14)
8.26
Buy
MACD (12,26)
-1.14
Sell
ADX (14)
35.36
Neutral
Williams %R
-92.56
Buy
CCI (14)
-112.78
Buy
ATR (14)
0.84
-
Ultimate Oscillator
29.29
Sell
ROC
-17.49
Sell
SAGE Therapeutics’s (SAGE) Relative Strength Index (RSI) is 31.83, creating a Neutral signal.
SAGE Therapeutics’s (SAGE) Trend Strength Indicator (ADX) is 35.36, creating a Neutral signal.
SAGE Therapeutics’s (SAGE) Commodity Channel Index (CCI) is -112.78, creating a Buy signal.
SAGE Therapeutics’s (SAGE) Price Rate of Change (ROC) is -17.49, creating a Sell signal.

FAQ

Is SAGE a Buy, Hold, or Sell?
Based on SAGE’s technical indicators, SAGE is a Strong Sell.
    What is SAGE’s RSI (14)?
    SAGE’s RSI (14) is 31.83, which suggests SAGE is a Neutral.
      What is SAGE’s MACD?
      SAGE’s MACD is -1.14, which suggests SAGE is a Sell.
        What is SAGE’s 5-day moving average?
        SAGE’s 5-day moving average is 11.91, which suggests SAGE is a Sell.
          What is SAGE’s 20-day moving average?
          SAGE 20-day moving average is 12.90, which suggests SAGE is a Sell.
            What is SAGE’s 50-day moving average?
            SAGE’s 50-day moving average is 15.83, which suggests SAGE is a Sell.
              What is SAGE’s 200-day moving average?
              SAGE’s 200-day moving average is 20.08, which suggests SAGE is a Sell.
                What is SAGE’s Williams % R (14)?
                SAGE’s Williams % R (14) is -92.56, which suggests SAGE is a Buy.
                  What is SAGE’s CCI (14)?
                  SAGE’s CCI (14) is -112.78, which suggests SAGE is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis